WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 8.90p on 12-11-2026 at 18:35:10 |
|---|---|
| Change | 0.10p 1.14% |
| Buy | 9.05p |
| Sell | 8.80p |
| Last Trade: | Unknown 700,000.00 at 8.90p |
| Day's Volume: | 1,697,103 |
| Last Close: | 8.90p |
| Open: | 8.80p |
| ISIN: | GB0008025412 |
| Day's Range | 8.80p - 9.05p |
| 52wk Range: | 6.72p - 10.70p |
| Market Capitalisation: | £102.86m |
| VWAP: | 8.914249p |
| Shares in Issue: | 1.16b |
SIG (SHI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 700,000 | 8.90p | OTC Trade |
17:07:34 - 12-Nov-26 |
| Buy* | 840 | 8.90p | Automatic Execution |
16:35:11 - 12-Nov-26 |
| Buy* | 32,997 | 8.90p | Suspected BUY Trade |
16:35:10 - 12-Nov-26 |
| Sell* | 200,000 | 8.90p | Ordinary |
16:08:18 - 12-Nov-26 |
| Sell* | 60,000 | 8.85p | SI Trade |
15:50:49 - 12-Nov-26 |
| Sell* | 14,050 | 8.91p | SI Trade |
15:12:37 - 12-Nov-26 |
| Sell* | 2,676 | 8.90p | Ordinary |
14:48:11 - 12-Nov-26 |
| Sell* | 5,353 | 8.8336p | Ordinary |
13:26:16 - 12-Nov-26 |
| Sell* | 22,471 | 8.90p | Ordinary |
12:38:56 - 12-Nov-26 |
| Buy* | 22 | 8.87p | SI Trade |
12:36:30 - 12-Nov-26 |
SIG (SHI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Oct 2026 3:31 pm | RNS | Director/PDMR Shareholding |
| 21st Oct 2026 7:00 am | RNS | NED & Chair of Audit & Risk Committee Appointment |
| 14th Oct 2026 4:08 pm | RNS | Director/PDMR Shareholding |
| 9th Oct 2026 7:00 am | RNS | Chief Executive succession |
| 5th Oct 2026 3:51 pm | RNS | Director/PDMR Shareholding |
| 17th Aug 2026 4:19 pm | RNS | Holding(s) in Company |
| 6th Aug 2026 4:30 pm | RNS | Holding(s) in Company |
| 4th Aug 2026 7:00 am | RNS | Results for the six months to 30 June 2026 |
| 16th Jul 2026 7:08 am | RNS | Post-close Trading Update |
| 8th Jun 2026 4:44 pm | RNS | Director/PDMR Shareholding |